Exact Mass: 386.216524
Exact Mass Matches: 386.216524
Found 500 metabolites which its exact mass value is equals to given mass value 386.216524
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sufentanil
Sufentanil is only found in individuals that have used or taken this drug. It is an opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent. [PubChem]Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Sufentanils analgesic activity is, most likely, due to its conversion to morphine. Opioids open calcium-dependent inwardly rectifying potassium channels (OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AH - Opioid anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
Euglobal Ia1
Euglobal Ia2 is a constituent of Eucalyptus globulus (tasmanian blue gum) Constituent of Eucalyptus globulus (Tasmanian blue gum).
Oleandolide
A 14-membererd macrolide containing ten stereocentres carrying one epoxymethano, three hydroxy and five methyl substituents. It is the aglycone of the antibiotic oleandomycin.
Euglobal Ib
Euglobal IIa is a constituent of Eucalyptus globulus (Tasmanian blue gum) Constituent of Eucalyptus globulus (Tasmanian blue gum).
Euglobal IIc
Euglobal IIc is a constituent of Eucalyptus globulus (Tasmanian blue gum)
Euglobal IIb
Euglobal IIb is a constituent of Eucalyptus globulus (Tasmanian blue gum)
17-phenyl-18,19,20-trinor-prostaglandin E2
17-phenyl-18,19,20-trinor-prostaglandin E2, also known as 17-Phenyl-omega-trinor-pge2 or CL 116147, is classified as a member of the Prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. 17-phenyl-18,19,20-trinor-prostaglandin E2 is considered to be practically insoluble (in water) and acidic. 17-phenyl-18,19,20-trinor-prostaglandin E2 is an eicosanoid lipid molecule
17-phenyl-18,19,20-trinor-prostaglandin D2
17-phenyl-18,19,20-trinor-prostaglandin D2 is also known as 17-Phenyl-omega-trinor-PGD2. 17-phenyl-18,19,20-trinor-prostaglandin D2 is considered to be practically insoluble (in water) and acidic
10,11-dihydro-20-trihydroxy-leukotriene B4
10,11-dihydro-20-trihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 10,11-Dihydro-20-trihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)
(Z)-7-[(1R,2R,3R,5S)-2-(1,2-Dihydroxy-3-oxooctyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid
8-(3,4-Dimethoxyphenyl)-7-methyl-1,3-dipropyl-1H-purine-2,6(3H,7H)-dione
C20H26N4O4 (386.19539560000004)
Butyryl timolol
C17H30N4O4S (386.19876600000003)
Oliceridine
TIC10
TIC10 isomer
1-[Fluoro(methoxy)phosphoryl]oxyicosa-5,8,11,14-tetraene
C21H36FO3P (386.23859680000004)
Ankaflavin
Ankaflavin is a natural product found in Monascus purpureus and Monascus pilosus with data available.
Trichodermadiene
Roseoside
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
4-amino-3-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-2-methyl-4-oxobutanoicacid
C20H26N4O4 (386.19539560000004)
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1h-indazole-3-carboxamide
C21H30N4O3 (386.23177899999996)
11-hydroxy-4-en-3,9-dioxo-megastigmane-11-O-beta-D-glucopyranoside|chaihuxinoside A
1-acetyl-16-methoxy-aspidospermidine-17,21-diol|3-Methoxy-limapodin
7alpha-Acetoxy-4,4,8-trimethyl-5alpha-17-oxa-androsta-1,14-dien-3,16-dione|beta-nimolactone
Euglobal IIc
3beta,7beta,8beta,12zeta,17-pentahydroxylabdan-16,15-olide
6-Deoxy-2-O-methyl-3-C-methuyltalose, 9CI-alpha-L-furanose-form-Me glycoside, 3,5-dibenzyl|6-Deoxy-2-O-methyl-3-C-methuyltalose, 9CI-beta-L-Furanose-form-Me glycoside, 3,5-dibenzyl
1-(2,6,6-trimethyl-4-hydroxycyclohexenyl)-1-hydroxybuta-1-en-3-one 4-O-beta-D-glucopyranoside
3-beta-hydroxy-beta-inone 11alpha-O-beta-D-glucopyranoside|pedicurexoside
(3S,10S,13R,14S)-3,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
6-(3,4-Methulenedioxybenzoyl)-8-Daucene-4,6-diol|jaeskeanidin
17-nor-15-oxo-8,11,13-abietatrien-18-butanedioic acid|abiesanordine L
7alpha,8alpha-Epoxide,3-O-beta-D-glucopyranoside-3-Hydroxy-5,7-megastigmadien-9-one|Icariside B2
Icariside B1
Icariside B1 is a natural product found in Staphylea bumalda, Grevillea robusta, and other organisms with data available.
SUFENTANIL
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AH - Opioid anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
(4S)-4-hydroxy-3,5,5-trimethyl-4-[(E)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]cyclohex-2-en-1-one
6-[(2E,4E,6E)-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-2,4,6-trien-2-yl]-4-methoxy-5-methylpyran-2-one
C19H30O8_3-Buten-2-one, 4-[4-(beta-D-glucopyranosyloxy)-2-hydroxy-2,6,6-trimethylcyclohexylidene]
C19H30O8_2-Cyclohexen-1-one, 4-[(1E)-3-(beta-D-glucopyranosyloxy)-4-hydroxy-1-buten-1-yl]-3,5,5-trimethyl-, (4R)
C19H30O8_2-Cyclohexen-1-one, 4-[(1E)-3-(beta-D-glucopyranosyloxy)-1-buten-1-yl]-4-hydroxy-3,5,5-trimethyl-, (4S)
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
(2R,2R,4aS,6R,8aS)-4,6-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzo[2,1-b:3,4-c]difuran-2,1-naphthalen]-6(8H)-one
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845048]
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845049]
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid_major
2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid_minor
[(5R,5aS,9aS,9bS)-9b-hydroxy-6,6,9a-trimethyl-1-oxo-3,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-5-yl] (2E,4E,6E)-octa-2,4,6-trienoate
Ala Ile Pro Ser
Ala Ile Ser Pro
Ala Leu Pro Ser
Ala Leu Ser Pro
Ala Pro Ile Ser
Ala Pro Leu Ser
Ala Pro Ser Ile
Ala Pro Ser Leu
Ala Pro Thr Val
Ala Pro Val Thr
Ala Ser Ile Pro
Ala Ser Leu Pro
Ala Ser Pro Ile
Ala Ser Pro Leu
Ala Thr Pro Val
Ala Thr Val Pro
Ala Val Pro Thr
Ala Val Thr Pro
Gly Ile Pro Thr
Gly Ile Thr Pro
Gly Leu Pro Thr
Gly Leu Thr Pro
Gly Pro Ile Thr
Gly Pro Leu Thr
Gly Pro Thr Ile
Gly Pro Thr Leu
Gly Thr Ile Pro
Gly Thr Leu Pro
Gly Thr Pro Ile
Gly Thr Pro Leu
Ile Ala Pro Ser
Ile Ala Ser Pro
Ile Gly Pro Thr
Ile Gly Thr Pro
Ile Pro Ala Ser
Ile Pro Gly Thr
Ile Pro Ser Ala
Ile Pro Thr Gly
Ile Ser Ala Pro
Ile Ser Pro Ala
Ile Thr Gly Pro
Ile Thr Pro Gly
Leu Ala Pro Ser
Leu Ala Ser Pro
Leu Gly Pro Thr
Leu Gly Thr Pro
Leu Pro Ala Ser
Leu Pro Gly Thr
Leu Pro Ser Ala
Leu Pro Thr Gly
Leu Ser Ala Pro
Leu Ser Pro Ala
Leu Thr Gly Pro
Leu Thr Pro Gly
Pro Ala Ile Ser
Pro Ala Leu Ser
Pro Ala Ser Ile
Pro Ala Ser Leu
Pro Ala Thr Val
Pro Ala Val Thr
Pro Gly Ile Thr
Pro Gly Leu Thr
Pro Gly Thr Ile
Pro Gly Thr Leu
Pro Ile Ala Ser
Pro Ile Gly Thr
Pro Ile Ser Ala
Pro Ile Thr Gly
Pro Leu Ala Ser
Pro Leu Gly Thr
Pro Leu Ser Ala
Pro Leu Thr Gly
Pro Ser Ala Ile
Pro Ser Ala Leu
Pro Ser Ile Ala
Pro Ser Leu Ala
Pro Thr Ala Val
Pro Thr Gly Ile
Pro Thr Gly Leu
Pro Thr Ile Gly
Pro Thr Leu Gly
Pro Thr Val Ala
Pro Val Ala Thr
Pro Val Thr Ala
Ser Ala Ile Pro
Ser Ala Leu Pro
Ser Ala Pro Ile
Ser Ala Pro Leu
Ser Ile Ala Pro
Ser Ile Pro Ala
Ser Leu Ala Pro
Ser Leu Pro Ala
Ser Pro Ala Ile
Ser Pro Ala Leu
Ser Pro Ile Ala
Ser Pro Leu Ala
Thr Ala Pro Val
Thr Ala Val Pro
Thr Gly Ile Pro
Thr Gly Leu Pro
Thr Gly Pro Ile
Thr Gly Pro Leu
Thr Ile Gly Pro
Thr Ile Pro Gly
Thr Leu Gly Pro
Thr Leu Pro Gly
Thr Pro Ala Val
Thr Pro Gly Ile
Thr Pro Gly Leu
Thr Pro Ile Gly
Thr Pro Leu Gly
Thr Pro Val Ala
Thr Val Ala Pro
Thr Val Pro Ala
Val Ala Pro Thr
Val Ala Thr Pro
Val Pro Ala Thr
Val Pro Thr Ala
Val Thr Ala Pro
Val Thr Pro Ala
17-phenyl trinor 8-iso Prostaglandin E2
17-phenyl trinor Prostaglandin D2
15-keto-17-phenyl trinor PGF2&alpha
Corchoionoside C
Euglobal Ib
Euglobal IIb
citroside A
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
Sonchuionoside C
(3E)-1-Hydroxy-4-[(1R)-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-buten-2-yl ?-D-glucopyranoside
FA 19:4;O6
butane-1,4-diol,dimethyl benzene-1,4-dicarboxylate,2-methyloxirane,oxirane
Anecortave Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Corchoionol C 9-glucoside
Constituent of Corchorus olitorius (Jews mallow). Corchoionol C 9-glucoside is found in many foods, some of which are tea, capers, green vegetables, and herbs and spices.
1,3-Bis(3-methacryloxypropyl)tetramethyldisiloxane
N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,hexanedioic acid,N-methylmethanamine
C15H35ClN4O5 (386.22958500000004)
KF 17837S
C20H26N4O4 (386.19539560000004)
butyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid,prop-2-enoic acid
Medibazine
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
butyl 2-methylprop-2-enoate,2-hydroxypropyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate
Oliceridine
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist N - Nervous system > N02 - Analgesics > N02A - Opioids
7-Benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5(4H)-one
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C174048 - ERK Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor D000970 - Antineoplastic Agents
Bevenopran
C20H26N4O4 (386.19539560000004)
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist
7-Benzyl-10-(2-methylbenzyl)-2,3,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(10H)-one
(RS)-Butyryltimolol
C17H30N4O4S (386.19876600000003)
(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol[1]. Butyryltimolol is a β-adrenergic blocker[2].
1-Butyl-8-(3-noradamantyl)-3-(3-hydroxypropyl)xanthine
C21H30N4O3 (386.23177899999996)
PSB36 is a potent and selective antagonist of adenosine A1 receptor, with Kis 0.12 nM, 187 nM, 552 nM, 2300 nM, and 6500 nM for rA1, hA2B, rA2A, hA3 and rA3 receptors respectively. PSB36 can be used for the research of hyperalgesia[1][2].
N-(4,6-dimethyl-2-pyrimidinyl)-1,3-bis(phenylmethyl)-2,4-dihydro-1,3,5-triazin-6-amine
1-[4-[3-[4-(4-Fluorophenyl)-1-piperazinyl]-2-hydroxypropoxy]phenyl]-1-propanone
(8R)-8-({3,6-dideoxy-4-O-[(2E)-2-methylbut-2-enoyl]-alpha-L-arabino-hexopyranosyl}oxy)nonanoic acid
3-(5-{[4-(Aminomethyl)piperidin-1-Yl]methyl}-1h-Indol-2-Yl)quinolin-2(1h)-One
5-[(3r)-3-(5-Methoxy-3,5-Dimethylbiphenyl-3-Yl)but-1-Yn-1-Yl]-6-Methylpyrimidine-2,4-Diamine
5-[(3r)-3-(5-Methoxy-2,6-Dimethylbiphenyl-3-Yl)but-1-Yn-1-Yl]-6-Methylpyrimidine-2,4-Diamine
6-[N-(1-Isopropyl-1,2,3,4-tetrahydro-7-isoquinolinyl)carbamyl]-2-naphthalenecarboxamidine
N-{[(2s,3s)-3-(Ethoxycarbonyl)oxiran-2-Yl]carbonyl}-L-Isoleucyl-L-Isoleucine
(1s,3r,4s,5s,7s)-4-{[2-(4-Methoxyphenoxy)-2-Methylpropanoyl]amino}adamantane-1-Carboxamide
(S)-N-(4-Carbamimidoylbenzyl)-1-(2-(Cyclohexyloxy)ethanoyl)pyrrolidine-2-Carboxamide
C21H30N4O3 (386.23177899999996)
Corchoionol C 9-glucoside
Constituent of Vitis vinifera cv. Gewürztraminer. 6e,9e-Dihydroxy-4,7E-megastigmadien-3-one 9-glucoside is found in alcoholic beverages and fruits. Corchoionol C 9-glucoside is found in capers. Corchoionol C 9-glucoside is a constituent of Corchorus olitorius (Jews mallow) D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
Roseoside I
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids 6e,9e-dihydroxy-4,7e-megastigmadien-3-one 9-glucoside is a member of the class of compounds known as fatty acyl glycosides of mono- and disaccharides. Fatty acyl glycosides of mono- and disaccharides are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol. 6e,9e-dihydroxy-4,7e-megastigmadien-3-one 9-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 6e,9e-dihydroxy-4,7e-megastigmadien-3-one 9-glucoside can be found in alcoholic beverages and fruits, which makes 6e,9e-dihydroxy-4,7e-megastigmadien-3-one 9-glucoside a potential biomarker for the consumption of these food products.
1-[Fluoro(methoxy)phosphoryl]oxyicosa-5,8,11,14-tetraene
C21H36FO3P (386.23859680000004)
(E)-7-[2-(1,2-dihydroxy-3-oxooctyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid
12-Methyl-5-dehydroacetylhorminone
An abietane diterpenoid that is the acetate ester of 12-methyl-5-dehydrohorminone. Isolated from the roots of Salvia multicaulis, it exhibits antitubercular activity.
8-[4-(2,3-Dihydro-1,4-benzodioxin-3-ylmethylamino)butyl]-8-azaspiro[4.5]decane-7,9-dione
3,5,5-Trimethyl-4beta-hydroxy-4-[3-(beta-D-glucopyranosyloxy)-1-butenyl]-2-cyclohexene-1-one
4-[4-(beta-D-glucopyranosyloxy)-2-hydroxy-2,6,6-trimethylcyclohexylidene]-3-Buten-2-one
2-(8-methoxy-4-methyl-1-oxo-[1,2,4]triazino[4,5-a]indol-2-yl)-N-(3-propan-2-yloxypropyl)acetamide
C20H26N4O4 (386.19539560000004)
[2-oxo-2-(prop-2-enylcarbamoylamino)ethyl] (E)-2-cyano-3-[2,5-dimethyl-1-(2-methylpropyl)pyrrol-3-yl]prop-2-enoate
C20H26N4O4 (386.19539560000004)
N-[4-[(2R,3R)-3-(hydroxymethyl)-4-[(1-methylimidazol-2-yl)methyl]-5-oxomorpholin-2-yl]phenyl]-2-methylpropanamide
C20H26N4O4 (386.19539560000004)
17-phenyl-18,19,20-trinor-prostaglandin E2
A prostanoid that is 18,19,20-trinor-prostaglandin E2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group.
(4R,7R)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C21H30N4O3 (386.23177899999996)
(4S,7S)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C21H30N4O3 (386.23177899999996)
(5S,8S)-8-[(4-methoxyphenyl)methyl]-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
C21H30N4O3 (386.23177899999996)
N-ethyl-N-[[(2S,3R,4S)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-ethyl-N-[[(2R,3R,4R)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
2,6-Ditert-butyl-4-(4-methoxyphenyl)pyrylium;tetrafluoroborate
(4S,7R)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C21H30N4O3 (386.23177899999996)
(4R,7S)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
C21H30N4O3 (386.23177899999996)
(5S,8R)-8-[(4-methoxyphenyl)methyl]-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
C21H30N4O3 (386.23177899999996)
N-ethyl-N-[[(2R,3S,4S)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-ethyl-N-[[(2S,3S,4S)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
N-ethyl-N-[[(2S,3R,4R)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxyacetamide
[(2R,3S)-3-phenyl-1,6-bis(pyridin-4-ylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
[(1S)-1-[[(2R)-2-(1,4-dihydropyrazine-2-carbonylamino)-3-phenylpropanoyl]amino]-3-methylbutyl]boronic acid
6-[4-[1-[(3S)-3-hydroxycyclohexyl]-2H-tetrazol-1-ium-5-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
C20H28N5O3+ (386.21920380000006)
(5S,6Z,8E,12S,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid
(4S)-6-[4-(1-cyclohexyl-2H-tetrazol-1-ium-5-yl)butoxy]-4-hydroxy-3,4-dihydro-1H-quinolin-2-one
C20H28N5O3+ (386.21920380000006)
6-[4-[1-(3-hydroxycyclohexyl)-2H-tetrazol-1-ium-5-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
C20H28N5O3+ (386.21920380000006)
(2E,4E)-2,4,6-Octatrienoic acid [(5R)-1,3,5,5aalpha,6,7,8,9,9a,9balpha-decahydro-9balpha-hydroxy-6,6,9abeta-trimethyl-1-oxonaphtho[1,2-c]furan]-5beta-yl ester
(8xi,9xi,14xi,17xi)-3,14-Dihydroxy-19-oxocarda-4,20(22)-dienolide
(3-Decoxy-2-hydroxypropyl) 2,3-dihydroxypropyl hydrogen phosphate
6-[(2E,4E,6E)-4,6-dimethyl-7-(2,4,5-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-2-yl)hepta-2,4,6-trien-2-yl]-4-methoxy-5-methylpyran-2-one
(1R,2S,5R)-5-Methyl-2-(1-methyl-1-(2-naphthyl)ethyl)-cyclohexane-1-YL benzoate
17-phenyl-18,19,20-trinor-prostaglandin D2
A prostanoid that is 18,19,20-trinor-prostaglandin D2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group.
mbas#10
A 4-O-[(E)-2-methyl-2-butenoyl]ascaroside derived from (8R)-8-hydroxynonanoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
Butyryltimolol
C17H30N4O4S (386.19876600000003)
Butyryltimolol, an effective precursor of Timolol, improves the corneal penetration of Timolol[1]. Butyryltimolol is a β-adrenergic blocker[2].
(1r,3ar,4r,8as)-8a-hydroxy-1-isopropyl-3a,6-dimethyl-3-oxo-2,4,7,8-tetrahydro-1h-azulen-4-yl 4-methoxybenzoate
methyl (1e,3z,6r,7r,10z)-10-[(acetyloxy)methylidene]-6-[2-(furan-3-yl)ethyl]-6,7-dimethylcyclodeca-1,3-diene-1-carboxylate
4,6-dihydroxy-5-(3,7,11-trimethyl-10-oxododeca-2,6-dien-1-yl)-3h-2-benzofuran-1-one
1,3-dihydroxy-7-isopropyl-10a-methyl-4-(3-methylbutanoyl)-5,8,8a,9-tetrahydroxanthene-2-carbaldehyde
(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16s)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol
1,2,4-trimethyl (1s)-1-(dec-9-en-1-yl)-2-hydroxybutane-1,2,4-tricarboxylate
(3r,3ar,4s,8as)-3-hydroxy-3-isopropyl-6,8a-dimethyl-8-oxo-2,3a,4,5-tetrahydro-1h-azulen-4-yl 4-methoxybenzoate
(1'r,2s,4r,5's)-5,7-dihydroxy-5'-isopropyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.0]hexane]-6,8-dicarbaldehyde
6,8-dihydroxy-2,14,14-trimethyl-7-(3-methylbutanoyl)-3-oxatetracyclo[11.1.1.0²,¹¹.0⁴,⁹]pentadeca-4,6,8-triene-5-carbaldehyde
(4r)-3-(hydroxymethyl)-5,5-dimethyl-4-[(1e,3s)-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one
5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-hydroxy-2-(2-hydroxypropan-2-yl)-1-benzofuran-4-yl acetate
(4as,7as,7br)-3-(hydroxymethyl)-6,6,7b-trimethyl-1h,2h,4h,4ah,5h,7h,7ah-cyclobuta[e]inden-2-yl 2,4-dihydroxy-6-methylbenzoate
(1s,3r,4s,6r,7r,8r,9s,10r,13r,14s,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol
1',2',5'-trimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl 5-(3-methyloxiran-2-yl)penta-2,4-dienoate
(2r,4s,5's)-5,7-dihydroxy-6',6'-dimethyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-6,8-dicarbaldehyde
3,5-dimethyl-4-(3-oxobutyl)-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one
(2r)-2-hydroxy-3,5,5-trimethyl-4-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-3-en-1-one
3,4-diformyl-4-hydroxy-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1h-naphthalen-1-yl octa-2,4,6-trienoate
1,3-dihydroxy-10a-isopropyl-7-methyl-2-(3-methylbutanoyl)-5,8,8a,9-tetrahydroxanthene-4-carbaldehyde
(4s)-3-(hydroxymethyl)-5,5-dimethyl-4-[(1e,3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one
4-[4-hydroxy-2,6-dimethyl-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-1-en-1-yl]but-3-en-2-one
3-{1-hydroxy-2-[2,3,6-trihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]ethyl}oxolan-2-one
(1'r,2r,4s,5'r)-5,7-dihydroxy-4',4'-dimethyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,3'-bicyclo[3.2.0]heptane]-6,8-dicarbaldehyde
1,3-dihydroxy-6-isopropyl-8a-methyl-2-(3-methylbutanoyl)-7,8,9,10a-tetrahydroxanthene-4-carbaldehyde
(5r,5as,9as,9bs)-9b-hydroxy-6,6,9a-trimethyl-1-oxo-3h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl (2z,4e,6e)-octa-2,4,6-trienoate
(4r)-4-hydroxy-3,5,5-trimethyl-4-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one
5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol
(4r)-4-[(1e,3s)-3-hydroxybut-1-en-1-yl]-5,5-dimethyl-3-({[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one
7-hydroxy-4,4-dimethyl-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4a,5,6,8-tetrahydro-3h-naphthalen-2-one
(4s)-4-hydroxy-3,5,5-trimethyl-4-[(1e,3r)-3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one
6-[(2e,4e,6e)-4,6-dimethyl-7-[(1s,2s,4r,5r)-2,4,5-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-2-yl]hepta-2,4,6-trien-2-yl]-4-methoxy-5-methylpyran-2-one
4,6'-dihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[1-benzofuran-2,1'-naphthalene]-6,7-dicarbaldehyde
methyl (4ar,5s,6r,8as)-8a-[(acetyloxy)methyl]-5-[2-(furan-3-yl)ethyl]-5,6-dimethyl-4a,6,7,8-tetrahydronaphthalene-1-carboxylate
2-(1-oxo-1-{[2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]methoxy}propan-2-yl)oct-2-enoic acid
1,3-dihydroxy-8a-isopropyl-6-methyl-2-(3-methylbutanoyl)-7,8,9,10a-tetrahydroxanthene-4-carbaldehyde
5,7-dihydroxy-3,3,4'-trimethyl-8-(3-methylbutanoyl)-4h-spiro[1-benzopyran-2,1'-cyclohexan]-3'-ene-6-carbaldehyde
(6S,9R)-roseside
{"Ingredient_id": "HBIN012813","Ingredient_name": "(6S,9R)-roseside","Alias": "NA","Ingredient_formula": "C19H30O8","Ingredient_Smile": "CC1=CC(=O)CC(C1(C=CC(C)OC2C(C(C(C(O2)CO)O)O)O)O)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42819","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
apocynoside i
{"Ingredient_id": "HBIN016508","Ingredient_name": "apocynoside i","Alias": "NA","Ingredient_formula": "C19H30O8","Ingredient_Smile": "CC(C=CC1C(=CC(=O)CC1(C)C)COC2C(C(C(C(O2)CO)O)O)O)O","Ingredient_weight": "386.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1529","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11025480","DrugBank_id": "NA"}
austroside b
{"Ingredient_id": "HBIN017385","Ingredient_name": "austroside b","Alias": "NA","Ingredient_formula": "C19H30O8","Ingredient_Smile": "CC(=O)C=C=C1C(CC(CC1(C)O)OC2C(C(C(C(O2)CO)O)O)O)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2023","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3e)-4-[(1r,4s,6r)-2,2,6-trimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-oxabicyclo[2.2.1]heptan-1-yl]but-3-en-2-one
(1'r,2r,4s,5'r)-5,7-dihydroxy-6',6'-dimethyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-6,8-dicarbaldehyde
(1r,3as,5ar,9as,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-dodecahydrocyclopenta[a]phenanthrene-7,11-dione
7-isopropyl-6-methoxy-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9-tetrahydrophenanthren-9-yl acetate
(7s,8r,11s,12r,13s)-11-hydroxy-3-(hydroxymethyl)-7,11-dimethyl-7-(4-methylpent-3-en-1-yl)-6,15-dioxatetracyclo[10.2.1.0⁵,¹⁴.0⁸,¹³]pentadeca-1(14),2,4-triene-2-carbaldehyde
(4r)-4-hydroxy-3,5,5-trimethyl-4-[(1e,3r)-3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one
(8ar,10ar)-1,3-dihydroxy-6-isopropyl-8a-methyl-4-(3-methylbutanoyl)-7,8,9,10a-tetrahydroxanthene-2-carbaldehyde
(3r,3as,4s,8ar)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl 2h-1,3-benzodioxole-5-carboxylate
(4r)-4-hydroxy-3,5,5-trimethyl-4-[(1e,3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one
9b-hydroxy-6,6,9a-trimethyl-1-oxo-3h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl octa-2,4,6-trienoate
7,9-dihydroxy-13,14,14-trimethyl-8-(3-methylbutanoyl)-4-oxatetracyclo[10.2.1.0³,¹³.0⁵,¹⁰]pentadeca-5,7,9-triene-6-carbaldehyde
(1r,2s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-2,3,4,6,9,14,16-heptol
(4as,9r)-7-isopropyl-6-methoxy-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9-tetrahydrophenanthren-9-yl acetate
5,7-dihydroxy-6',6'-dimethyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-6,8-dicarbaldehyde
2,6,6,12-tetramethyltetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecane-2,4,5,7,8,10,12-heptol
(1's,2'r,7'r,9'r,11'r)-1',2',5'-trimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e)-5-[(2r,3r)-3-methyloxiran-2-yl]penta-2,4-dienoate
(1s)-1-[(1r,4as,11ar)-1-(acetyloxy)-7-methyl-11-methylidene-1h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-4-yl]penta-3,4-dien-1-yl acetate
4-(3-hydroxybut-1-en-1-yl)-5,5-dimethyl-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one
4-(2,2,6-trimethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-oxabicyclo[4.1.0]heptan-1-yl)but-3-en-2-one
4-(4-hydroxy-2,6,6-trimethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-1-en-1-yl)but-3-en-2-one
(7r,8as,10ar)-1,3-dihydroxy-7-isopropyl-10a-methyl-2-(3-methylbutanoyl)-7,8,8a,9-tetrahydroxanthene-4-carbaldehyde
(1r,2r,4as,6r,8as)-6,7'-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-2h-3',11'-dioxaspiro[naphthalene-1,4'-tricyclo[7.3.0.0²,⁶]dodecane]-1',6',8'-trien-12'-one
(1r,3r,4s,6r,7r,8r,11r,15s)-6-methyl-17,18-dioxo-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-en-7-yl 2-methylpropanoate
(7r,8as,9r,10as)-1,3-dihydroxy-7-isopropyl-10a-methyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-2,4-dicarbaldehyde
(1'r,2s,5's)-5,7-dihydroxy-6',6'-dimethyl-6-(3-methylbutanoyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-8-carbaldehyde
4,6-dihydroxy-5-[(2e,6e)-3,7,11-trimethyl-10-oxododeca-2,6-dien-1-yl]-3h-2-benzofuran-1-one
(4r,5s)-4-[(1e,3r)-3-hydroxybut-1-en-1-yl]-3,5-dimethyl-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one
(3e)-4-(4-hydroxy-2,6,6-trimethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-1-en-1-yl)but-3-en-2-one
(9s,10r)-3,4,5,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaene
11-(2-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)undecan-1-one
(3e)-4-[(1r,4s,6s)-2,2,6-trimethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-oxabicyclo[4.1.0]heptan-1-yl]but-3-en-2-one
(1's,2s,2'r,7'r,9'r,11'r)-1',2',5'-trimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e)-5-[(2r,3r)-3-methyloxiran-2-yl]penta-2,4-dienoate
(7r,8ar,9r,10ar)-1,3-dihydroxy-7-isopropyl-10a-methyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-2,4-dicarbaldehyde
(7s,8ar,9s,10ar)-1,3-dihydroxy-7-isopropyl-10a-methyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-2,4-dicarbaldehyde
5,7-dihydroxy-6',6'-dimethyl-6-(3-methylbutanoyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-8-carbaldehyde
(3e)-4-[(3r,4s)-4-hydroxy-2,6,6-trimethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-1-en-1-yl]but-3-en-2-one
(3r)-3-[(1s)-2-[(1r,2s,3s,4ar,6s,8as)-2,3,6-trihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]oxolan-2-one
(1'r,2s,4s,5's)-5,7-dihydroxy-5'-isopropyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.0]hexane]-6,8-dicarbaldehyde
(4s)-4-[(1e,3r)-4-hydroxy-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]-3,5,5-trimethylcyclohex-2-en-1-one
(2s)-5,7-dihydroxy-3,3,4'-trimethyl-8-(3-methylbutanoyl)-4h-spiro[1-benzopyran-2,1'-cyclohexan]-3'-ene-6-carbaldehyde
(6s,12bs)-12-hydroxy-3,4,10,11-tetramethoxy-6-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium
[C22H28NO5]+ (386.19673780000005)
1,3-dihydroxy-6-isopropyl-8a-methyl-4-(3-methylbutanoyl)-7,8,9,10a-tetrahydroxanthene-2-carbaldehyde
(8as,10as)-1,3-dihydroxy-7-isopropyl-10a-methyl-2-(3-methylbutanoyl)-5,8,8a,9-tetrahydroxanthene-4-carbaldehyde
4-(4-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl)-3,5,5-trimethylcyclohex-2-en-1-one
7-{[(1r,2s,4ar,5s,6s,8ar)-2,6-dihydroxy-2,5,8a-trimethyl-octahydronaphthalen-1-yl]methoxy}chromen-2-one
(1's,2s,4r,5'r)-5,7-dihydroxy-5'-isopropyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.0]hexane]-6,8-dicarbaldehyde
(2s,4s,4'r)-5,7-dihydroxy-4'-isopropyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,1'-cyclohexan]-2'-ene-6,8-dicarbaldehyde
(3e)-4-[(3r,4s)-3-hydroxy-2,6,6-trimethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-1-en-1-yl]but-3-en-2-one
(7r,8ar,10ar)-1,3-dihydroxy-7-isopropyl-10a-methyl-2-(3-methylbutanoyl)-7,8,8a,9-tetrahydroxanthene-4-carbaldehyde
(6r,12bs)-9-hydroxy-3,4,10,11-tetramethoxy-6-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium
[C22H28NO5]+ (386.19673780000005)